Identification of an Upstream Promoter of the Human Somatostatin Receptor, hSSTR2, Which Is Controlled by Epigenetic Modifications-Reference-Cited by-同舟云学术

Identification of an Upstream Promoter of the Human Somatostatin Receptor, hSSTR2, Which Is Controlled by Epigenetic Modifications

Published:2008-03-06 Issue:6 Volume:149 Page:3137-3147
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Torrisani Jérôme¹,Hanoun Naïma¹,Laurell Henrik¹,Lopez Frédéric²,Maoret Jean-José²,Souque Anny¹,Susini Christiane¹,Cordelier Pierre¹,Buscail Louis¹³

Affiliation:

1. Institut National de la Santé et de la Recherche Médicale Unité 858-I2MR (J.T., N.H., H.L., A.S., C.S., P.C., L.B.), Institut de Médecine Moléculaire de Rangueil, Département Cancers Epithéliaux, Angiogénèse, et Signalisation, 31432 Toulouse Cedex 4, France

2. Institut Fédératif de Recherche 31 (F.L., J.-J.M.), Toulouse Rangueil, Plateformes de Génomique et Biologie Moléculaire/Protéomique et Intéractions Moléculaires, Centre Hospitalier Universitaire Rangueil, 31059 Toulouse, France

3. Service de Gastroentérologie (L.B.), Centre Hospitalier Universitaire Rangueil, 31059 Toulouse, France

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/149/6/3137/9004458/endo3137.pdf

Reference46 articles.

1. Physiology of somatostatin receptors.;Guillermet-Guibert;J Endocrinol Invest,2005

2. Somatostatin: the neuroendocrine story.;Gillies;Trends Pharmacol Sci,1997

3. Rationale for the use of somatostatin analogs as antitumor agents.;Susini;Ann Oncol,2006

4. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors.;Kvols;Anticancer Drugs,2006